Reference:
1. Hossain I, Khan MH, Rahman MS, Mullick AR, Aktaruzzaman M. The
epidemiological characteristics of an outbreak of 2019 novel coronavirus
diseases (COVID-19) in Bangladesh: A descriptive study. Journal of
Medical Science and Clinical Research. 2020;8(04).
2. Macera M, De Angelis G, Sagnelli C, Coppola N, COVID V. Clinical
presentation of COVID-19: case series and review of the literature. Int
J Environ Res Public Health. 2020;17(14):5062.
3. Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with
hemoptysis: acute segmental pulmonary emboli associated with novel
coronavirus infection. The American journal of emergency medicine.
2020;38(7):1544. e1-. e3.
4. Chowdhury PB, Hossain S, Biswas RK. A combination of COVID-19 and
dengue fever in Bangladesh: Preparedness of Bangladesh. Journal of
Global Health. 2020;10(2).
5. Dengue and severe dengue WHO | World Health Organization:
WHO | World Health Organization; 2021 [cited 2021 10 july
2021]. Available from:
https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
6. Gagnon S, Quigley N, Dutau H, Delage A, Fortin M. Approach to
hemoptysis in the modern era. Can Respir J. 2017;2017.
7. Singh V, Mishra SC, Singh P, Pradeepa A. Dengue Infection Induced
Diffuse Alveolar Hemorrhage. Journal of Case Reports. 2020;10(2):68-71.
8. Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment
of hemoptysis. Deutsches Ärzteblatt International. 2017;114(21):371.
9. Shi F, Yu Q, Huang W, Tan C. 2019 novel coronavirus (COVID-19)
pneumonia with hemoptysis as the initial symptom: CT and clinical
features. Korean journal of radiology. 2020;21(5):537.
10. Marchiori E, Hochhegger B, Zanetti G. Pulmonary manifestations of
dengue. Jornal Brasileiro de Pneumologia. 2020;46.
11. Mohan K, Nasimuddin S, Sathyaseelan RD, Meenakshisundaram PR,
Gnanadesikan S, Malaiyan J. A study on clinical profile and laboratory
parameters of dengue fever patients in Chennai, Tamil Nadu, India.
12. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of
immune response during SARS-CoV-2 infection: lessons from the past.
Front Immunol. 2020;11:1949.
13. Du F, Liu B, Zhang S. COVID-19: the role of excessive cytokine
release and potential ACE2 down-regulation in promoting hypercoagulable
state associated with severe illness. J Thromb Thrombolysis.
2021;51(2):313-29.
14. Mazzeffi MA, Chow JH, Tanaka K. COVID-19 associated
hypercoagulability: manifestations, mechanisms, and management. Shock
(Augusta, Ga). 2021;55(4):465.